Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Apelin Signaling Pathway: Role in Blood Pressure and Obesity, Slides of Biology

The discovery and biological effects of apelin, a new vasodilator substance and a member of the renin-angiotensin system. Apelin interacts with its receptor apj and has various functions including lowering blood pressure, regulating heart and blood vessel contraction, insulin secretion, and pituitary hormone release. The imbalance between apelin and angiotensin ii may contribute to hypertension and heart diseases such as heart failure, coronary heart disease, and atrial fibrillation. Apelin is also expressed in obesity and related diseases, and can inhibit the release of vasopressin, affecting kidney disease.

What you will learn

  • What are the biological effects of Apelin?
  • What is Apelin and how does it function in the body?
  • How is the imbalance between Apelin and angiotensin II related to hypertension and heart diseases?

Typology: Slides

2018/2019

Uploaded on 09/02/2019

Immunologycc
Immunologycc 🇺🇸

78 documents

1 / 1

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Apelin Signaling Pathway
There are many substances that relax blood vessels in the body, such as NO,
prostacyclin, vasoactive intestinal peptide, etc. Recently, another vasodilator
substance, Apelin, has been discovered. In 1993, Carroll et al. discovered a protein
similar in structure to angiotensin II type 1 receptor, named angiotensin type 1
receptor-associated protein, also known as APJ, which belongs to the G-protein
coupled family. In 1998, Tatemoto et al. extracted the APJ endogenous ligand named
Apelin from bovine gastric secretion, which is a new adipocytokine and forms an
Apelin/APJ system with APJ. Apelin is homologous to angiotensin II (AngII) and is a
new member of the renin-angiotensin system (RAS). Apelin has many biological
effects such as lowering blood pressure, regulating heart and blood vessel
contraction, insulin secretion, pituitary hormone release, and humoral balance.
The Apelin/APJ system together with AngII-AT1 antagonism maintains blood pressure
homeostasis, and the imbalance between the two may be an important factor in the
development of hypertension. Recently, studies have found that Apelin may be
associated with heart diseases such as heart failure, coronary heart disease, atrial
fibrillation, and as a new adipokine, Apelin is expressed in obesity with insulin
resistance, regulation of fatty insulin axis and obesity-related diseases (such as
hypertension, type 2 diabetes, etc.). In addition, Apelin can also inhibit the release of
vasopressin, which has a diuretic effect, and has a certain relationship with kidney
disease.
Apelin family
Carroll et al. found that Apelin mRNA was expressed in the mammary gland, lung,
cardiovascular, brain, kidney, testis, ovary and skeletal muscle of rats, and expressed
in the breast and lung, vascular endothelium, adipose tissue and gastric parietal cells.
In humans, Apelin is mainly expressed in vascular endothelial cells of heart, kidney
and lung, and is less expressed in cardiomyocytes, lung, kidney, adrenal secretory
cells, vascular smooth muscle cells, adipose tissue, and nerve cells. The human apelin
gene is located on chromosome Xq25-26 and consists of three exons and two introns.
https://www.creative-diagnostics.com/apelin-signaling-pathway.htm

Partial preview of the text

Download Apelin Signaling Pathway: Role in Blood Pressure and Obesity and more Slides Biology in PDF only on Docsity!

Apelin Signaling Pathway

There are many substances that relax blood vessels in the body, such as NO, prostacyclin, vasoactive intestinal peptide, etc. Recently, another vasodilator substance, Apelin, has been discovered. In 1993, Carroll et al. discovered a protein similar in structure to angiotensin II type 1 receptor, named angiotensin type 1 receptor-associated protein, also known as APJ, which belongs to the G-protein coupled family. In 1998, Tatemoto et al. extracted the APJ endogenous ligand named Apelin from bovine gastric secretion, which is a new adipocytokine and forms an Apelin/APJ system with APJ. Apelin is homologous to angiotensin II (AngII) and is a new member of the renin-angiotensin system (RAS). Apelin has many biological effects such as lowering blood pressure, regulating heart and blood vessel contraction, insulin secretion, pituitary hormone release, and humoral balance.

The Apelin/APJ system together with AngII-AT1 antagonism maintains blood pressure homeostasis, and the imbalance between the two may be an important factor in the development of hypertension. Recently, studies have found that Apelin may be associated with heart diseases such as heart failure, coronary heart disease, atrial fibrillation, and as a new adipokine, Apelin is expressed in obesity with insulin resistance, regulation of fatty insulin axis and obesity-related diseases (such as hypertension, type 2 diabetes, etc.). In addition, Apelin can also inhibit the release of vasopressin, which has a diuretic effect, and has a certain relationship with kidney disease.

Apelin family

Carroll et al. found that Apelin mRNA was expressed in the mammary gland, lung, cardiovascular, brain, kidney, testis, ovary and skeletal muscle of rats, and expressed in the breast and lung, vascular endothelium, adipose tissue and gastric parietal cells. In humans, Apelin is mainly expressed in vascular endothelial cells of heart, kidney and lung, and is less expressed in cardiomyocytes, lung, kidney, adrenal secretory cells, vascular smooth muscle cells, adipose tissue, and nerve cells. The human apelin gene is located on chromosome Xq25-26 and consists of three exons and two introns.

https://www.creative-diagnostics.com/apelin-signaling-pathway.htm